EKTAY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:57):

Stats
Šios dienos apimtis	14 150.00
Vidutinė apimtis	9 630.00
Rinkos kapitalizacija	2.71B
EPS	$0 ( 2024-03-01 )
Kita pelno data	( $0 ) 2024-06-05
Last Dividend	$0.117 ( 2023-08-25 )
Next Dividend	$0 ( N/A )
P/E	20.79
ATR14	$0.0430 (0.61%)

Elekta AB (publ) Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Elekta AB (publ) Finansinės ataskaitos

Annual	2023
Pajamos:	$16.87B
Bruto pelnas:	$6.35B (37.64 %)
EPS:	$2.47

FY	2023
Pajamos:	$16.87B
Bruto pelnas:	$6.35B (37.64 %)
EPS:	$2.47

FY	2022
Pajamos:	$14.55B
Bruto pelnas:	$5.44B (37.37 %)
EPS:	$3.02

FY	2021
Pajamos:	$13.76B
Bruto pelnas:	$5.61B (40.76 %)
EPS:	$3.28

Financial Reports:

No articles found.

Elekta AB (publ) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.118 (N/A)	$0 (N/A)	$0.118 (N/A)	$0 (N/A)	$0.117 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Elekta AB (publ) Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.56 - Stable (11.21%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.305	2013-09-04
Last Dividend	$0.117	2023-08-25
Next Dividend	$0	N/A
Payout Date	2023-09-15
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	$1.985	--
Avg. Dividend % Per Year	0.00%	--
Score	3.93	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.56
Div. Directional Score	9.15	--

Next Divdend (Est)
(2024-10-03)

$0.123 Estimate 7.07 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.93

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SOBS	Ex Dividend Knight	2023-06-29	Quarterly	0.00%
GTMEY	Ex Dividend Knight	2023-08-28	Quarterly	0.00%
AGRIP	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
NHMD	Ex Dividend Junior	2023-08-30	Semi-Annually	0.00%
CNTHP	Ex Dividend Knight	2023-07-07	Quarterly	0.00%
THNPY	Ex Dividend Knight	2023-05-18	Annually	0.00%
HSNGY	Ex Dividend Knight	2023-08-11	Quarterly	0.00%
ASHTY	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%
PHPPY	Ex Dividend Junior	2023-05-18	Annually	0.00%
DSKYF	Ex Dividend Knight	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0786	1.500	8.43	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0466	1.200	8.45	10.00	[0 - 0.3]
returnOnEquityTTM	0.141	1.500	9.54	10.00	[0.1 - 1]
payoutRatioTTM	0.640	-1.000	3.60	-3.60	[0 - 1]
currentRatioTTM	1.095	0.800	9.53	7.62	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.181	1.500	-0.104	-0.156	[0.2 - 2]
debtRatioTTM	0.198	-1.500	6.70	-10.00	[0 - 0.6]
interestCoverageTTM	6.24	1.000	8.80	8.80	[3 - 30]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.98	2.00	8.01	10.00	[0 - 20]
debtEquityRatioTTM	0.593	-1.500	7.63	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.377	1.000	7.04	7.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.129	1.000	9.41	9.41	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.516	1.000	8.25	8.25	[0.2 - 2]
assetTurnoverTTM	0.593	0.800	9.38	7.50	[0.5 - 2]
Total Score				12.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.39	1.000	8.04	0	[1 - 100]
returnOnEquityTTM	0.141	2.50	9.70	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.98	2.00	8.67	10.00	[0 - 30]
dividendYielPercentageTTM	0.0283	1.500	9.29	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
payoutRatioTTM	0.640	1.500	3.60	-3.60	[0 - 1]
pegRatioTTM	-0.104	1.500	-4.02	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.172	1.000	8.20	0	[0.1 - 0.5]
Total Score				5.56

Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.